BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bär F, Sina C, Fellermann K. Thiopurines in inflammatory bowel disease revisited. World J Gastroenterol 2013; 19(11): 1699-1706 [PMID: 23555158 DOI: 10.3748/wjg.v19.i11.1699]
URL: https://www.wjgnet.com/1007-9327/full/v19/i11/1699.htm
Number Citing Articles
1
K. Herrlinger, K. Fellermann, E.F. Stange. Therapie chronisch-entzündlicher DarmerkrankungenDer Internist 2014; 55(8): 906 doi: 10.1007/s00108-013-3442-1
2
Ana Lúcia Sousa, Paulo Caldeira, Marta Eusébio, Alda Martins, Teresa Belo, Horácio Guerreiro. Azatioprina na doença inflamatória intestinal: fatores preditivos da resposta sustentada a longo prazoGE Jornal Português de Gastrenterologia 2014; 21(4): 147 doi: 10.1016/j.jpg.2014.05.002
3
Oren Ledder, Daniel A Lemberg, Andrew S Day. Thiopurine-induced pancreatitis in inflammatory bowel diseasesExpert Review of Gastroenterology & Hepatology 2015; 9(4): 399 doi: 10.1586/17474124.2015.992879
4
Masahiro Iizuka, Takeshi Etou, Yosuke Shimodaira, Takashi Hatakeyama, Shiho Sagara. Cytapheresis re-induces high-rate steroid-free remission in patients with steroid-dependent and steroid-refractory ulcerative colitisWorld Journal of Gastroenterology 2021; 27(12): 1194-1212 doi: 10.3748/wjg.v27.i12.1194
5
Masahiro Iizuka, Takeshi Etou, Shiho Sagara. Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapyWorld Journal of Gastroenterology 2022; 28(34): 4959-4972 doi: 10.3748/wjg.v28.i34.4959
6
Arvind I. Srinath, Neera Gupta, Sohail Z. Husain. Probing the Association of Pancreatitis in Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2016; 22(2): 465 doi: 10.1097/MIB.0000000000000611
7
X. Y. Qiu, M. J. Lu, H. J. Zhang. Editorial: weighing the global risk of cancer with thiopurines in inflammatory bowel disease-Authors' replyAlimentary Pharmacology & Therapeutics 2018; 47(5): 690 doi: 10.1111/apt.14498
8
Adriana Guerra Romero, José Lázaro Pérez Calle, Pilar López Serrano. Submaxilitis aguda secundaria a la toma de azatioprina en paciente con enfermedad de CrohnGastroenterología y Hepatología 2018; 41(9): 570 doi: 10.1016/j.gastrohep.2017.10.001
9
Rangnath Mishra, Punita Dhawan, Anand S Srivastava, Amar B Singh. Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapyWorld Journal of Stem Cells 2020; 12(10): 1050-1066 doi: 10.4252/wjsc.v12.i10.1050
10
Adriana Guerra Romero, José Lázaro Pérez Calle, Pilar López Serrano. Azathioprine-induced acute submandibular sialadenitis in a patient with Crohn's diseaseGastroenterología y Hepatología (English Edition) 2018; 41(9): 570 doi: 10.1016/j.gastre.2018.11.001
11
Thomas Klag, Martin Goetz, Eduard F. Stange, Jan Wehkamp. Medical Therapy of Perianal Crohn's DiseaseVisceral Medicine 2015; 31(4): 265 doi: 10.1159/000434664
12
Martin Kummen, Erik Schrumpf, Kirsten Muri Boberg. Liver abnormalities in bowel diseasesBest Practice & Research Clinical Gastroenterology 2013; 27(4): 531 doi: 10.1016/j.bpg.2013.06.013
13
M. Raúl Acuña. Patología colorrectalRevista Médica Clínica Las Condes 2014; 25(1): 114 doi: 10.1016/S0716-8640(14)70017-3
14
Najjia N. Mahmoud, Yasmin Halwani, Sandra de Montbrun, Puja M. Shah, Traci L. Hedrick, Farzana Rashid, David A. Schwartz, Robin L. Dalal, Jan P. Kamiński, Karen Zaghiyan, Phillip R. Fleshner, Jason M. Weissler, John P. Fischer. Current management of perianal Crohn’s diseaseCurrent Problems in Surgery 2017; 54(5): 262 doi: 10.1067/j.cpsurg.2017.02.003
15
Katarína Maráková, Juraj Piešťanský, Peter Mikuš. Determination of Drugs for Crohn’s Disease Treatment in Pharmaceuticals by Capillary Electrophoresis Hyphenated with Tandem Mass SpectrometryChromatographia 2017; 80(4): 537 doi: 10.1007/s10337-016-3213-y
16
Masahiro Iizuka, Takeshi Etou, Makoto Kumagai, Atsushi Matsuoka, Yuka Numata, Shiho Sagara. Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative ColitisInternal Medicine 2017; 56(20): 2705 doi: 10.2169/internalmedicine.8428-16
17
Marçal Pastor-Anglada, Sandra Pérez-Torras. Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targetsFrontiers in Pharmacology 2015; 6 doi: 10.3389/fphar.2015.00013
18
N. M. Heerasing, J. F. Ng, D. Dowling. Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?Internal Medicine Journal 2016; 46(4): 465 doi: 10.1111/imj.12915
19
Salvatore Cucchiara, Marina Aloi. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition2016; : 323 doi: 10.1007/978-3-319-17169-2_28
20
Kendra Kamp, Amanda Holmstrom, Zhehui Luo, Gwen Wyatt, Barbara Given. Factors Influencing Received Social Support Among Emerging Adults With Inflammatory Bowel DiseaseGastroenterology Nursing 2020; 43(6): 429 doi: 10.1097/SGA.0000000000000483
21
Galen Leung, Marianna Papademetriou, Shannon Chang, Francis Arena, Seymour Katz. Interactions Between Inflammatory Bowel Disease Drugs and ChemotherapyCurrent Treatment Options in Gastroenterology 2016; 14(4): 507 doi: 10.1007/s11938-016-0109-8
22
Katarína Maráková, Juraj Piešťanský, Zuzana Zelinková, Peter Mikuš. Capillary Electrophoresis Hyphenated with Mass Spectrometry for Determination of Inflammatory Bowel Disease Drugs in Clinical Urine SamplesMolecules 2017; 22(11): 1973 doi: 10.3390/molecules22111973
23
Carole Rouiller-Braunschweig, Nicolas Fournier, Valérie Pittet, Jean Dudler, Pierre Michetti. Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease PatientsDigestion 2017; 96(4): 220 doi: 10.1159/000482007
24
Arvind Srinath, Erin Young, Eva Szigethy. Pain Management in Patients with Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2014; 20(12): 2433 doi: 10.1097/MIB.0000000000000170
25
Fatih Karaahmet, Hakan Akinci, Rasit Ayte, Mevlut Hamamci, Yusuf Coskun, Ilhami Yuksel. Tremor as dose dependent side-effect of azathioprine in remission patient with ileal Crohn's diseaseJournal of Crohn's and Colitis 2013; 7(9): e404 doi: 10.1016/j.crohns.2013.04.010
26
Yueying Chen, Jun Shen. Core indicators of an evaluation and guidance system for quality of care in inflammatory bowel disease centers: A critical revieweClinicalMedicine 2022; 46: 101382 doi: 10.1016/j.eclinm.2022.101382
27
Axel Dignass, Ayesha Akbar, Ailsa Hart, Sreedhar Subramanian, Gilles Bommelaer, Daniel C. Baumgart, Jean-Charles Grimaud, Guillaume Cadiot, Richard Makins, Syed Hoque, Guillaume Bouguen, Bruno Bonaz. Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim ResultsJournal of Crohn's and Colitis 2016; 10(7): 812 doi: 10.1093/ecco-jcc/jjw032
28
Colin B. Peirce, Matthew F. Kalady. Fundamentals of Anorectal Surgery2019; : 531 doi: 10.1007/978-3-319-65966-4_29
29
Marta Freitas, Tiago Lima Capela, Vítor Macedo Silva, Cátia Arieira, Tiago Cúrdia Gonçalves, Francisca Dias de Castro, Maria João Moreira, João Firmino-Machado, José Cotter. Finding Predictors of Azathioprine-Induced Pancreatitis in Patients With Inflammatory Bowel DiseasePancreas 2022; 51(3): 288 doi: 10.1097/MPA.0000000000002012
30
Ramya Movva, Alison Haywood, Sohil A Khan, Timothy HJ Florin, Iulia Oancea. Critical assessment of thioguanine treatment for inflammatory bowel diseases: Is it time to rehabilitate this treatment?Journal of Digestive Diseases 2017; 18(9): 529 doi: 10.1111/1751-2980.12536
31
Anita Annaházi, Tamás Molnár. Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug WithdrawalGastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/832395
32
Chi-Chun Ho, Wai-Ying Fong, Yuen-Hon Lee, Wing-Tat Poon. Novel Tetra-Primer ARMS-PCR Assays for Thiopurine Intolerance Susceptibility Mutations NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C) in East AsiansGenes 2017; 8(10): 285 doi: 10.3390/genes8100285
33
Nicholas M. Ruel, Khanh H. Nguyen, Gonzalo Vilas, James R. Hammond. Characterization of 6-Mercaptopurine Transport by the SLC43A3-Encoded Nucleobase TransporterMolecular Pharmacology 2019; 95(6): 584 doi: 10.1124/mol.118.114389
34
Hong-Hui Wang, Ying He, Hong-Xian Wang, Cheng-Ling Liao, Yu Peng, Li-Jian Tao, Wei Zhang, Hui-Xiang Yang. Comparison of <i>TPMT</i> and <i>NUDT15</i> polymorphisms in Chinese patients with inflammatory bowel diseaseWorld Journal of Gastroenterology 2018; 24(8): 941-948 doi: 10.3748/wjg.v24.i8.941
35
Nicholas V. Costrini. Clearing of the Clouds in Inflammatory Bowel Disease ManagementDigestive Diseases and Sciences 2020; 65(12): 3411 doi: 10.1007/s10620-020-06635-2
36
Younes El Gamrani, Khadija Krati. Les effets indésirables des thiopurines au cours du traitement d’entretien de la maladie de CrohnHegel 2017; (2): 107 doi: 10.3917/heg.072.0107
37
M.A. Payeras Capó, A. Escarda Gelabert, A. Erimeiku Barahona, I. Pérez Medrano, E. Antón Valentí, D. Ginard Vicens. Hiperplasia nodular regenerativa: hepatotoxicidad por 6-mercaptopurina en un paciente con enfermedad de CrohnEnfermedad Inflamatoria Intestinal al Día 2017; 16(2): 84 doi: 10.1016/j.eii.2016.12.008